A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.
Connectivity between the amygdala and specific brain regions may predict headache reduction after cognitive behavioral therapy for adolescent migraine.
Migraine has a considerable impact on women’s pregnancy plans, with about 20 percent avoiding pregnancy due to migraine.
While calcitonin gene related peptide antibodies are effective for episodic and chronic migraine, most of its benefits are from contextual effects.
Pooled prevalence of migraine was 31 percent in MS patients, with significant variance internationally.
Patients with vestibular migraine are more likely to have occipital headaches than those without vestibular symptoms.
Acute sleep deprivation may cause increased frequency of cortical spreading depolarization and reduce its electrical threshold.
Compared with healthy control participants, pediatric patients with chronic migraine reported a higher rate of depression.
Approximately one-third of patients with migraine reported using opioids to treat their symptoms, a practice that contrasts with current guidelines.
Mechanical pain thresholds may be used to predict the next headache attack in patients with migraine.
